DMARD

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

By

Tocilizumab was associated with significant improvements in hemoglobin and hematocrit over 2 years of treatment in patients with rheumatoid arthritis.

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked With Higher Infection Risk

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked With Higher Infection Risk

By

Children with juvenile idiopathic arthritis using anti-TNFIs have a significantly higher risk for infection compared with children using DMARDs.

Rheumatoid Arthritis Treatment Initiated Early on Shows Good Long-Term Outcomes

Rheumatoid Arthritis Treatment Initiated Early on Shows Good Long-Term Outcomes

By

Patients with RA who were treated in the first 6 months had a lower risk of death.

Rheumatoid, IBD Treatments and Risk of Breast Cancer Recurrence

Rheumatoid, IBD Treatments and Risk of Breast Cancer Recurrence

No statistically significant association was found between MTX or anti-TNF use and breast cancer recurrence.

Reassessing the Efficacy of Gold Therapy for Rheumatoid Arthritis

Reassessing the Efficacy of Gold Therapy for Rheumatoid Arthritis

Significant clinical improvement was reported after adding intramuscular gold therapy to methotrexate.

Benefits of Intensive Pain Control in Early Rheumatoid Arthritis

Benefits of Intensive Pain Control in Early Rheumatoid Arthritis

By

Much of the disability associated with RA relates to the pain secondary to inflammatory joint inflammation.

Sign Up for Free e-Newsletters